Member Info for uxm484

Clearly Nick cannot be trusted. He feels Porky should be on the board. This is very upsetting for holders.

Porky made the statement below. He clearly wants Valirx to fail.

Good luck - ultimately Adam will either take a proper position on the board or possibly sell the lot out and buy the key assets in a liquidation and merge them into his own business, frankly the latter is what I would do - the current BOD are not fit to advance this business in their current format IMO

Well maybe he has agreed a way forward. Could he be joining the BOD soon?

The fact that it appears he has backed BOD suggests that he backs the strategy provided they do not dilute more for assets at these prices. As we understand BOD has agreed that is the way forward as confirmed in the video.

Worth noting guys even Satu stated she felt the strategy will produce significant profit. I think those that know will also know this will bring significant value and investment to the company along with our compounds.

Only 7 million valuation for everything we have.

Slightly more risk at lower prices such as the current price but a very easy ten bagger to 70p with just one deal. A bit of risk here but very high reward play here. You take a chance and make it big by buying big here or lose 20/30% most likely temporarily.

Good to buy at these prices and keep it on the shelf for 6-12 months and see what happens.

Personally I think Suzy owes it to shareholders who have always backed her the least they can do is buy a chunk at these prices and make themselves good money. I think they will soon.

For the greater good of Valirx posters/readers alike we don't enjoy reading your waffles. GL, DYOR.

Freddieboy,

I suspect it will just be your blood boiling at the AGM. GL.

Nothing to counter just don't want to listen to bull. If you think you can do better then step up. Keyboard warrior.

OK shut up. Bored of your stupid posts.

Already had cash until mid 2024 but should soon be making profit by the end of the year imo.

Inaphaea BioLabs Operational Update

London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health, announces an operational update from the Company's wholly owned subsidiary, Inaphaea BioLabs Limited ("Inaphaea").

Inaphaea has entered into an agreement with the Virtual CRO services company OncoBone Limited ("OncoBone") whereby clients of OncoBone can access Inaphaea services. OncoBone offers a service to virtual biotech and other biopharma clients whereby OncoBone designs and commissions pre-clinical work on behalf of the client. To conduct the laboratory work, OncoBone engages with a range of pre-clinical Contract Research Organisations ("CROs") to execute on the experimental designs that OncoBone has developed. Inaphaea is now confirmed as an OncoBone supplier of cell-based assays.

Additionally, Inaphaea is pleased to report that the cell-based assay services are now listed on scientist.com, a database of CROs that can be used by biotechnology and pharmaceutical companies to search for scientific capabilities.

Dr Suzy Dilly, CEO at ValiRx explains "This operational update demonstrates the progress made by Inaphaea towards generating contract revenues. We're particularly excited by the prospect of working with OncoBone due to the innovative nature of their Virtual CRO service."

The Directors of the Company take responsibility for this announcement.

Porky you make wild assumptions. Every AIM stock has resolutions and just because they request overheads it doesn't mean they use it or all of it. An example being the options requested last year where they requested the same amount and only used about 10% percent of it. You obviously know this which proves you have an agenda. Maybe you are related to George or Sacu who knows. You don't know what you don't know.

We should get a significant RNS relating to CLX001 by next year whether it gets a deal or not by that time. Positive toxicology results could take the SP to 30-50p on that alone. You are right it is only worth what someone will pay for it so by advancing it they will get more money maybe 50 million upfront payment or more with huge milestone payments.

I'll leave you to your echo chamber. GL and DYOR.

Absolutely incredible, we should all be heeding the words of an individual who not only divested their significant share holdings but currently possesses a mere token amount around £150 worth of shares.

Just to clarify, Valirx has sufficient cash reserves until at least mid/late 2024, as verified in the Cenkos broker report recently. Anticipated significant revenue generation by the year's end will further extend their financial stability. With this timeline in mind, there is ample time for the completion of the 201 deal or CLX by late 2024, should it come to fruition. It's important to note that Valirx requested 20 million in cash, not 40 million. Market conditions on AIM should improve resulting in some decent uplift in SP at some stage and we should receive lots more news in the coming months.

Fantastic life changing entry point here with a hold for 1/2 years. GL, DYOR.

Valirx has progressed since 2021 as they now have CLX worth over 20 million, 201 LOI likely to complete as confirmed by BOD, 401, lab, Imagen Therapeutics and 301 likely to enter SPV soon. Somehow all that is not worth 3 million pounds to me.

Porky have you sold your 200k shares yet?

hello pink ***** cat,

what is a cso? why does suzy need to be cso over other candidates like cathy, zai etc. sorry i just need to understand what you are saying and why. what qualifications/experience does she have to become cso over anyone else currently working for valirx?

Pork's your making assumptions mate.

We can only go based on what BOD has stated. Trx are looking to complete. It could be wrong it could be right but that is what we go based on.

Pork,

BOD made it clear 201 financing will be finalised. SP moves to 50 p. Placing at 35 p.

If you had bothered watching the presentation you would have noticed they will be generating revenue soon. They have all the clients already from the recent asset purchase.

They have sufficient cash until next year. 8 P is a buy like it or not.

The compound had no value therefore the share price should not have gone down therefore a nice discount on offer.

IMO, DYOR, GL All..

I averaged it down today as well. So very happy I feel we will not get this opportunity again to average down at such prices.

Dracula,

Val will be generating significant revenue in the coming months. Enough cash for 12 months.

CLX update, 201 deal, 301, lab update. 20 p is a given imo. Depends how long folks wish to wait but I fell this will hit 50 p this year.

Wait until new compounds come in and this will be soon. 8p is a dream buy imo DYOR. GL all.

I have seen AIM stocks valued at 8 million with hardly nothing at all. Just a listing price.

DYOR now is the time to step it up and buy big.

This is now amazingly cheap. 50p target gets us a nice return. Just purchased a few today.

BOD is confident 201 will get done and that could be an instant 10 times current SP. New compounds to come, lab to generate big revenue and CLX.

I feel we are onto something big. The news today was a tiny set back.

Given you are the one constantly complaining then you should be providing the solutions other than simply stating replace BOD every day when you have no idea what you are talking about.

201 only has one hope and that is with TRX. As it has been stated by many including Suzy and Adam it is very hard to get a deal with old patents and low trial numbers. Why would a big pharma take 201 even for free if they have to risk losing money doing large trials. Suzy has stated they tend to take these types of drugs at phase 3.

The current strategy is perfect regarding SPV and university tie ups. It will return value with CLX and others once they come in. It is a low risk and low spend strategy.